Cabaletta Bio Inc. (CABA)
2.31
0.12 (5.48%)
At close: Jan 15, 2025, 10:28 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -67.67M | -52.98M | -46.29M | -33.34M | -16.94M | -12.20M | -333.33K |
| Depreciation & Amortization | 1.43M | 1.18M | 733.00K | 354.00K | 104.00K | n/a | n/a |
| Stock-Based Compensation | 11.34M | 6.90M | 5.80M | 4.39M | 2.30M | 606.00K | n/a |
| Other Working Capital | -1.57M | -4.27M | 4.61M | 1.15M | -1.75M | -698.00K | 81.33K |
| Other Non-Cash Items | 1.26M | 2.82M | 62.00K | 119.00K | 2.26M | 7.40M | 252.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -2.26M | n/a | n/a |
| Change in Working Capital | 101.00K | -4.30M | 5.58M | 1.71M | -1.51M | -464.00K | 81.33K |
| Operating Cash Flow | -53.55M | -46.38M | -34.11M | -26.77M | -16.05M | -4.66M | n/a |
| Capital Expenditures | -687.00K | -2.45M | -1.17M | -635.00K | -693.00K | n/a | n/a |
| Acquisitions | n/a | 24.76K | n/a | 7.35K | n/a | n/a | n/a |
| Purchase of Investments | -84.26M | -49.76M | n/a | -11.10M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 62.50M | 25.00M | 7.17M | 3.75M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -24.76K | 7.17K | -7.35K | n/a | n/a | n/a |
| Investing Cash Flow | -22.45M | -27.22M | 6.00M | -7.98M | -693.00K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | 12.54M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -192.00K | n/a | -169.00K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | -10.09M | n/a | n/a |
| Other Financial Acitivies | 4.86M | 127.00K | 650.00K | 168.00K | 58.80M | 25.14M | 1.33K |
| Financial Cash Flow | 187.63M | 32.98M | 48.90M | -24.00K | 119.92M | 37.68M | 1.33K |
| Net Cash Flow | 111.63M | -40.62M | 20.79M | -34.77M | 103.19M | 33.02M | 1.33K |
| Free Cash Flow | -54.24M | -48.83M | -35.27M | -27.41M | -16.74M | -4.66M | n/a |